MedPath

OCTREOSCAN

Diagnostic - For Intravenous Use.

Approved
Approval ID

93d8f3b2-1216-41dc-a63d-0e812b33891d

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 21, 2022

Manufacturers
FDA

Curium US LLC

DUNS: 079875617

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Indium In -111 Pentetreotide

PRODUCT DETAILS

NDC Product Code69945-050
Application NumberNDA020314
Marketing CategoryC73594
Route of AdministrationN/A
Effective DateDecember 22, 2021
Generic NameIndium In -111 Pentetreotide
© Copyright 2025. All Rights Reserved by MedPath
OCTREOSCAN - FDA Approval | MedPath